Dextenza 0.4Mg Ophthalmic Insert
Dextenza 0.4Mg Ophthalmic Insert is a pharmaceutical drug with 19 clinical trials. Historical success rate of 88.9%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
1
Mid Stage
15
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
8 of 12 finished
33.3%
4 ended early
0
trials recruiting
19
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
DEXTENZA in Pediatric Patients Following Retinal Surgery or Laser Treatment Under Anesthesia
Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking
Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery
Clinical Trials (19)
DEXTENZA in Pediatric Patients Following Retinal Surgery or Laser Treatment Under Anesthesia
Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking
Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery
The RESTORE Study, A Randomized, Controlled, Masked (Reading Center) Prospective Study
Efficacy of Dextenza Insert in Upper vs Lower Punctum Following Cataract Surgery With PCIOL.
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery
Efficacy and Safety of Dextenza Compared to Topical Fluorometholone in Patients With Ocular Rosacea
DEXTENZA for the Treatment of Postoperative Pain and Inflammation Following Vitreo-retinal Surgery
A Study for Post op Inflammation After Cataract Surgery
Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections
Comparison of the Postoperative Use of Dextenza vs a Standard Regimen After PRK
PREFERENTIAL Study
A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery
Evaluation Of Vision Recovery And Comfort Index In Patients With Borderline/Mild Dry Eyes Undergoing FLACS With Premium IOL
Pre-Surgical Ocular Surface Treatment With Intracanalicular Dexamethasone Insert And Effect On Intraocular Lens Measurement Accuracy
Dextenza Within Upper Lid Canaliculus Compared With Lower Lid Canaliculus Following Bilateral Cataract Extraction Surgery With PCIOL.
DEXTENZA Compared to Topical Prednisolone in Patients Undergoing Bilateral LASIK Surgery
All 19 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 19